Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maria Ester Bernardo

Showing results (11-20 of 107) with videos related to

Pageof 11
Sort By:
Hematology/Oncology Clinics of North America|June 30, 2022
Ex Vivo and In Vivo Gene Therapy for Mucopolysaccharidoses: State of the ArtGiulia Consiglieri, Maria Ester Bernardo, Nicola Brunetti-Pierri, et al.
Pediatric Radiology|April 9, 2008
Spinal osteomyelitis due to Aspergillus flavus in a child: a rare complication after haematopoietic stem cell transplantationGiampiero Beluffi, Maria Ester Bernardo, Giulia Meloni, et al.
Journal of Clinical Medicine|December 22, 2019
Bone Marrow-Derived Mesenchymal Stromal Cells: A Novel Target to Optimize Hematopoietic Stem Cell Transplantation Protocols in Hematological Malignancies and Rare Genetic DisordersStefania Crippa, Ludovica Santi, Roberto Bosotti, et al.
Journal of Inherited Metabolic Disease|June 1, 2017
Gene therapy for lysosomal storage disorders: recent advances for metachromatic leukodystrophy and mucopolysaccaridosis IRachele Penati, Francesca Fumagalli, Valeria Calbi, et al.
Frontiers in Cell and Developmental Biology|May 21, 2021
Role of <i>ex vivo</i> Expanded Mesenchymal Stromal Cells in Determining Hematopoietic Stem Cell Transplantation OutcomeStefania Crippa, Ludovica Santi, Margherita Berti, et al.
Annals of the New York Academy of Sciences|August 18, 2010
The role of reduced intensity preparative regimens in patients with thalassemia given hematopoietic transplantationAlice Bertaina, Maria Ester Bernardo, Angela Mastronuzzi, et al.
Best Practice & Research. Clinical Haematology|September 15, 2010
Cord blood transplantation in children with haematological malignanciesAlice Bertaina, Maria Ester Bernardo, Maurizio Caniglia, et al.
Italian Journal of Pediatrics|November 17, 2018
Gene therapy for mucopolysaccharidoses: in vivo and ex vivo approachesAlessandro Fraldi, Marta Serafini, Nicolina Cristina Sorrentino, et al.
Blood|June 21, 2007
Use of a DNAemia cut-off for monitoring human cytomegalovirus infection reduces the number of preemptively treated children and young adults receiving hematopoietic stem-cell transplantation compared with qualitative pp65 antigenemiaDaniele Lilleri, Giuseppe Gerna, Milena Furione, et al.
Journal of Children'S Orthopaedics|August 14, 2025
Ultrasonographic hip morphology in mucopolysaccharidosis type I Hurler after hematopoietic stem cell gene therapyMaurizio De Pellegrin, Chiara Filisetti, Matilde Cossutta, et al.
Pageof 11

Showing results (11-20 of 107) with videos related to

Sort By:
Pageof 11
Hematology/Oncology Clinics of North America|June 30, 2022
Ex Vivo and In Vivo Gene Therapy for Mucopolysaccharidoses: State of the ArtGiulia Consiglieri, Maria Ester Bernardo, Nicola Brunetti-Pierri, et al.
Pediatric Radiology|April 9, 2008
Spinal osteomyelitis due to Aspergillus flavus in a child: a rare complication after haematopoietic stem cell transplantationGiampiero Beluffi, Maria Ester Bernardo, Giulia Meloni, et al.
Journal of Clinical Medicine|December 22, 2019
Bone Marrow-Derived Mesenchymal Stromal Cells: A Novel Target to Optimize Hematopoietic Stem Cell Transplantation Protocols in Hematological Malignancies and Rare Genetic DisordersStefania Crippa, Ludovica Santi, Roberto Bosotti, et al.
Journal of Inherited Metabolic Disease|June 1, 2017
Gene therapy for lysosomal storage disorders: recent advances for metachromatic leukodystrophy and mucopolysaccaridosis IRachele Penati, Francesca Fumagalli, Valeria Calbi, et al.
Frontiers in Cell and Developmental Biology|May 21, 2021
Role of <i>ex vivo</i> Expanded Mesenchymal Stromal Cells in Determining Hematopoietic Stem Cell Transplantation OutcomeStefania Crippa, Ludovica Santi, Margherita Berti, et al.
Annals of the New York Academy of Sciences|August 18, 2010
The role of reduced intensity preparative regimens in patients with thalassemia given hematopoietic transplantationAlice Bertaina, Maria Ester Bernardo, Angela Mastronuzzi, et al.
Best Practice & Research. Clinical Haematology|September 15, 2010
Cord blood transplantation in children with haematological malignanciesAlice Bertaina, Maria Ester Bernardo, Maurizio Caniglia, et al.
Italian Journal of Pediatrics|November 17, 2018
Gene therapy for mucopolysaccharidoses: in vivo and ex vivo approachesAlessandro Fraldi, Marta Serafini, Nicolina Cristina Sorrentino, et al.
Blood|June 21, 2007
Use of a DNAemia cut-off for monitoring human cytomegalovirus infection reduces the number of preemptively treated children and young adults receiving hematopoietic stem-cell transplantation compared with qualitative pp65 antigenemiaDaniele Lilleri, Giuseppe Gerna, Milena Furione, et al.
Journal of Children'S Orthopaedics|August 14, 2025
Ultrasonographic hip morphology in mucopolysaccharidosis type I Hurler after hematopoietic stem cell gene therapyMaurizio De Pellegrin, Chiara Filisetti, Matilde Cossutta, et al.
Pageof 11